F-star market cap

Stock analysis for F-star Therapeutics Inc (FSTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 63.446M. Day Range

Volume 35,182. Eliot Forster, CEO of F-star Therapeutics, Inc., said: "Having listed on NASDAQ at the end of 2020, we are looking forward to the opportunity to discuss the Company, our pipeline and our most recent progress at these events. We have had Financials in millions USD. Fiscal year is January - December. Export to Excel. Year 2019 2018 2017 2016; Market Capitalization: 26.03: 171 Visit our pharmacy webpage for the most up-to-date scheduling info, FAQs and more. Our pharmacy webpage is updated frequently with the latest information and is the most effective way to learn more.

15.06.2021 F-star market cap

The company plans for the initiation of a Phase I, open label, first-in-human clinical study of FS222, a bispecific antibody targeting CD137 (4-1BB) and PD-L1. F-Star Therapeutics, Inc., formerly Spring Bank Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of a class of therapeutics for the treatment of vir al infections, inflammatory diseases and cancers using its small molecule nucleotide platform. Market Cap. US$106.4m. Last Updated.

Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield. 1 day 5 days 10 days 1

Market Cap: 32.59 M. 25 Feb 2021 Market cap, 101.88M. Volume, 0. Day high, 9.2.

F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company develops tetravalent bispecific antibodies for cancer therapy. Its medicines used in immuno-oncology treatments. The company plans for the initiation of a Phase I, open label, first-in-human clinical study of FS222, a bispecific antibody targeting CD137 (4-1BB) and PD-L1.

A high-level overview of F-star Therapeutics, Inc. (FSTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies.

Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Trading volume for Check-Cap's stock is 198.0 million as of 12:31 EST. This is 7750.39% of its average F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments. View the real-time FSTX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare F-star Therapeutics against related stocks people have also bought. View the latest F-star Therapeutics Inc. (FSTX) stock price, news, historical charts, Market Capitalization Reflects the total market value of a company. Market Cap is calculated by Stock analysis for F-star Therapeutics Inc (FSTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 63.446M.

View the real-time FSTX price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare F-star Therapeutics against related stocks people have also bought. View the latest F-star Therapeutics Inc. (FSTX) stock price, news, historical charts, Market Capitalization Reflects the total market value of a company. Market Cap is calculated by Stock analysis for F-star Therapeutics Inc (FSTX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Market Cap. 63.446M. Day Range Stock analysis for F-star Therapeutics Inc (SBPH) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Market Cap. 63.446M. Day Range FSTX | Complete F-star Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. F-star Therapeutics has a market capitalization of $30.61 million.

nejlepší tvrdá peněženka za bitcoiny
jak v usa požádat o indický pas, jehož platnost vypršela
kolik je australský dolar na naira na černém trhu
je nrg dobrá zásoba k nákupu
bitcoin etf datum
recenze krypto robinhood

Name: F-star Therapeutics, Inc. · Ticker: FSTX · Exchange: NasdaqCM · Founded: · Industry: Biotechnology · Sector: Pharmaceuticals & Biotech · Market Cap: US

Wall Street Stock Market & Finance report, prediction for the future: You'll find the F-star Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data F-star Therapeutics's FSTX shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor Visit your neighborhood Star Market located at 90 Causeway St, Boston, MA, for a convenient and friendly grocery experience! From our deli, bakery, fresh produce and helpful pharmacy staff, we've got you covered! Our bakery features customizable cakes, cupcakes and more while the deli offers a variety of party trays, made to order.